| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | INBX | Common Stock | Sale | -$520K | -22.2K | -1.03% | $23.41 | 2.13M | Jan 3, 2023 | By the Eckelman Living Trust dated February 5, 2014 | F1, F2, F3 |
| transaction | INBX | Common Stock | Sale | -$209K | -8.6K | -0.4% | $24.36 | 2.12M | Jan 3, 2023 | By the Eckelman Living Trust dated February 5, 2014 | F1, F3, F4 |
| transaction | INBX | Common Stock | Sale | -$52.3K | -2.08K | -0.1% | $25.09 | 2.12M | Jan 3, 2023 | By the Eckelman Living Trust dated February 5, 2014 | F1, F3, F5 |
| transaction | INBX | Common Stock | Sale | -$94.8K | -4.1K | -0.19% | $23.11 | 2.12M | Jan 4, 2023 | By the Eckelman Living Trust dated February 5, 2014 | F1, F3, F6 |
| transaction | INBX | Common Stock | Sale | -$72K | -3K | -0.14% | $23.99 | 2.12M | Jan 4, 2023 | By the Eckelman Living Trust dated February 5, 2014 | F1, F3, F7 |
| holding | INBX | Common Stock | 160K | Jan 3, 2023 | By trust | F8 | |||||
| holding | INBX | Common Stock | 160K | Jan 3, 2023 | By trust | F9 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | INBX | Stock Option (right to buy) | Award | $0 | +40K | $0.00 | 40K | Jan 3, 2023 | Common Stock | 40K | $23.30 | Direct | F10 |
| Id | Content |
|---|---|
| F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Eckelman Living Trust dated February 5, 2014. |
| F2 | The shares were sold in multiple transactions at prices ranging from $23.01 to $24.00, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. |
| F3 | These securities are directly owned by the Eckelman Living Trust dated February 5, 2014. Brendan P. Eckelman is the trustee of the Eckelman Living Trust dated February 5, 2014 and, in such capacity, may be deemed to indirectly beneficially own the securities owned by the Eckelman Living Trust dated February 5, 2014. |
| F4 | The shares were sold in multiple transactions at prices ranging from $24.01 to $24.99, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. |
| F5 | The shares were sold in multiple transactions at prices ranging from $25.02 to $25.48, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. |
| F6 | The shares were sold in multiple transactions at prices ranging from $22.60 to $23.56, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. |
| F7 | The shares were sold in multiple transactions at prices ranging from $23.61 to $24.41, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. |
| F8 | These securities are directly owned by a trust, for the benefit of Brendan P. Eckelman's minor son. Brendan P. Eckelman is the trustee of the trust, and, in such capacity, may be deemed to indirectly beneficially own the securities owned by the trust. |
| F9 | These securities are directly owned by a trust, for the benefit of Brendan P. Eckelman's minor daughter. Brendan P. Eckelman is the trustee of the trust, and, in such capacity, may be deemed to indirectly beneficially own the securities owned by the trust. |
| F10 | Twenty-five percent (25%) of the total shares subject to the stock option become exercisable on January 3, 2024, with the balance to vest and become exercisable in equal successive monthly installments forthirty-six (36) months thereafter. |